PAVIA ANNUAL MEETING 2018, TANZANIA
PAVIA BLENDED TRAINING IN COORDINATION WITH VERONA TEAM
PAVIA ANNUAL CONSORTIUM MEETING 2019, ETHIOPIA
3rd PAVIA training
The PAVIA project aims to strengthen pharmacovigilance (PV) in four African countries: Ethiopia, Eswatini, Nigeria, and Tanzania. To achieve this aim, collaborative support will be harnessed across several institutions in Europe and Africa.
Workpackage
WP2 is on Policy, Laws, and Regulations. In this WP, we will support the target countries to address the relevant policies… more
WP3 is about Data collection and Signal Detection, including Data Management Measures. In this WP, we work… more
WP4 deals with Monitoring and Evaluation. The objective of this WP is to measure the impact of our PV activities in a… more
WP5 entails System, Structure, and Stakeholder Measures. This WP aims to strengthen organizational structures… more
Our Achievements
-
PAVIA at 50th Union Conference
in ConferenceSymposium session proposal: Sustainable models for strengthening pharmacovigilance of TB m...
-
Safety and reporting of adverse events of new anti-tuberculosis drug regimens in Sub-Sahara Africa: Analysis of individual case safety reports.
in News, Report NigeriaThe main aim is to report the safety and management of adverse drugs reactions associated ...
-
-
The National Pharmacovigilance centre of Nigeria participated in the 2020 Med Safety week
Nigeria used this opportunity and launched the Med Safety App to boost ADR reportin...
-
PAVIA Country Specific Meeting Eswatini
National Pharmacovigilance unit annual PV planning meeting and Data capturing exercise fro...
-
Training report: Eswatini Active Drug-Safety Monitoring and Management (aDSM) System..
Training report: Eswatini Active Drug-Safety Monitoring and Management (aDSM) System in th...
What does the PAVIA team say
The Following People are Part of PAVIA
"Workpackage 5 lead"
Blandina Theophil Mmbaga- is a paediatrician at Kilimanjaro Christian Medical Centre (KCMC), Director of the Kilimanjaro Clinical Research Institute (KCRI), senior... read more
"Workpackage 3 lead"
Linda Härmark studied pharmacy at the University of Uppsala, Sweden. After graduation she relocated to the Netherlands where she joined the Netherlands... read more
"Workpackage 2 lead"
Professor Ambrose O. Isah graduated from the University of Ibadan Medical School in 1979 and had his residency training in Internal Medicine at the University of Benin Teaching Hospital... read more
"Steering Committee Member"
He is the Managing Director/Chief Operating Officer (MD/COO), of the Institute of Human Virology Nigeria and also an Ex-officio Director of the Board. He is responsible for the... read more
"Steering Committee Member"
She graduated in 2002 in Master of Science Chemistry and Pharmaceutical Technologies (Grade A cum laude). Since 2003 up to now she is working with a research contract at the... read more
"Steering Committee Member"
She is responsible for giving policy direction to the National Pharmaceutical Services of the Kingdom of Eswatini, Review of Pharmaceutical Legislations and Regulations, Development ... read more
Our Team
PV Coordinator: Eswatini
Alemayehu Duga
Workpackage 2 lead
Ambrose Isah
Workpackage 5 lead
Blandina Mmbaga
Overall project lead
Frank Cobelens
Assistant project manager
Henry Tumwijukye
PV Coordinator: Ethiopia
Kassech Sintayehu
Workpackage 3 lead
Linda Härmark
Project manager
Nina Schat
PV Coordinator: Tanzania
Seth Kisenge
Our Participants in PAVIA Project
Following are participants involved in PAVIA Project
News and Events
PAVIA at 50th Union Conference
Symposium session proposal: Sustainable models for strengthening pharmacovigilance of TB medicines and diagnostics: global and regional perspectives and country examples. . . ...
Safety and reporting of adverse events of new anti-tuberculosis drug regimens in Sub-Sahara Africa: Analysis of individual case safety reports.
The main aim is to report the safety and management of adverse drugs reactions associated with the use of new antituberculosis drugs in Nigeria, Tanzania, Ethiopia and Eswatini. The study will describe the demographic characteristic of the patients that reported adverse events with new and... ...
PAVIA blended training
PAVIA blended training in coordination with Verona team ...
Training report: Eswatini Active Drug-Safety Monitoring and Management (aDSM) System..
Training report: Eswatini Active Drug-Safety Monitoring and Management (aDSM) System in the Implementation of New Drugs Training Report This report summarizes the training sessions. ...